Literature DB >> 3560134

Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemia.

D P Mikhailidis, M A Barradas, P Dandona.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3560134      PMCID： PMC1290647          DOI： 10.1177/014107688708000127

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  5 in total

1.  Effects of prostaglandin E2, analogs, fatty acids, and indomethacin on fibrinogen level.

Authors:  T H Carlson; S H Wentland; B D Leonard; M A Ruder; E B Reeve
Journal:  Am J Physiol       Date:  1978-08

2.  The fibrinolytic system and coagulation during bezafibrate treatment of hypertriglyceridemia.

Authors:  L O Almér; T Kjellström
Journal:  Atherosclerosis       Date:  1986-07       Impact factor: 5.162

3.  Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease.

Authors:  D P Mikhailidis; M A Barradas; A Maris; J Y Jeremy; P Dandona
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

4.  Hypertriglyceridaemia and hypercoagulability.

Authors:  H C Simpson; J I Mann; T W Meade; R Chakrabarti; Y Stirling; L Woolf
Journal:  Lancet       Date:  1983-04-09       Impact factor: 79.321

5.  The effect of dihomogammalinolenic acid on platelet aggregation and prostaglandin release, erythrocyte membrane fatty acids and serum lipids: evidence for defects in PGE1 synthesis and delta 5-desaturase activity in insulin-dependent diabetics.

Authors:  D P Mikhailidis; S J Kirtland; M A Barradas; S Mahadeviah; P Dandona
Journal:  Diabetes Res       Date:  1986-01
  5 in total
  1 in total

1.  Changes in blood lipids and fibrinogen with a note on safety in a long term study on the effects of n-3 fatty acids in subjects receiving fish oil supplements and followed for seven years.

Authors:  R Saynor; T Gillott
Journal:  Lipids       Date:  1992-07       Impact factor: 1.880
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.